Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209–249

Article  Google Scholar 

Tang LL, Chen WQ, Xue WQ et al (2016) Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett 374:22–30

CAS  Article  Google Scholar 

Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. Lancet 394:64–80

Article  Google Scholar 

Chan SC, Yeh CH, Yen TC et al (2018) Clinical utility of simultaneous whole-body (18)F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging 45:1297–1308

Article  Google Scholar 

Guo R, Mao YP, Tang LL et al (2019) The evolution of nasopharyngeal carcinoma staging. Br J Radiol 92:20190244

Article  Google Scholar 

Stan DJ, Niculet E, Lungu M et al (2022) Nasopharyngeal carcinoma: A new synthesis of literature data (Review). Exp Ther Med 23:136

CAS  Google Scholar 

Shen G, Zhang W, Jia Z, Li J, Wang Q, Deng H (2014) Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma. Br J Radiol 87:20140296

CAS  Article  Google Scholar 

Ng SH, Chan SC, Yen TC et al (2009) Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging 36:12–22

Article  Google Scholar 

Syed M, Flechsig P, Liermann J et al (2020) Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers. Eur J Nucl Med Mol Imaging 47:2836–2845

CAS  Article  Google Scholar 

Scanlan MJ, Raj BK, Calvo B et al (1994) Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A 91:5657–5661

CAS  Article  Google Scholar 

Chen J, Yang P, Xiao Y et al (2017) Overexpression of alpha-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis. J Cancer 8:3897–3902

Article  Google Scholar 

Thompson LD (2007) Update on nasopharyngeal carcinoma. Head Neck Pathol 1:81–86

Article  Google Scholar 

Gong L, Kwong DL, Dai W et al (2021) The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment. Front Oncol 11:744889

Article  Google Scholar 

Loktev A, Lindner T, Mier W et al (2018) A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts. J Nucl Med 59:1423–1429

CAS  Article  Google Scholar 

Loktev A, Lindner T, Burger EM et al (2019) Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention. J Nucl Med 60:1421–1429

CAS  Article  Google Scholar 

Li Y, Lin X, Li Y, et al (2022) Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study. Mol Imaging Biol 24:309–320

Ristau J, Giesel FL, Haefner MF et al (2020) Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer. Mol Imaging Biol 22:1495–1500

CAS  Article  Google Scholar 

Chen H, Pang Y, Wu J et al (2020) Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging 47:1820–1832

Article  Google Scholar 

Kratochwil C, Flechsig P, Lindner T et al (2019) (68)Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med 60:801–805

CAS  Article  Google Scholar 

Chen H, Zhao L, Ruan D et al (2021) Usefulness of [(68)Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [(18)F]FDG PET/CT findings. Eur J Nucl Med Mol Imaging 48:73–86

Article  Google Scholar 

Qin C, Liu F, Huang J et al (2021) A head-to-head comparison of (68)Ga-DOTA-FAPI-04 and (18)F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study. Eur J Nucl Med Mol Imaging 48:3228–3237

CAS  Article  Google Scholar 

Zhao L, Pang Y, Zheng H et al (2021) Clinical utility of [(68)Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging 48:3606–3617

CAS  Article  Google Scholar 

Liu B, Zhang Z, Wang H, Yao S (2019) Preclinical evaluation of a dual sstr2 and integrin alphavbeta3-targeted heterodimer [(68)Ga]-NOTA-3PEG4-TATE-RGD. Bioorg Med Chem 27:115094

CAS  Article  Google Scholar 

van den Brekel MW, Stel HV, Castelijns JA et al (1990) Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 177:379–384

Article  Google Scholar 

Zhang GY, Liu LZ, Wei WH, Deng YM, Li YZ, Liu XW (2010) Radiologic criteria of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma treated with radiation therapy. Radiology 255:605–612

Article  Google Scholar 

Henry LR, Lee HO, Lee JS et al (2007) Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res 13:1736–1741

CAS  Article  Google Scholar 

Dohi O, Ohtani H, Hatori M et al (2009) Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours. Histopathology 55:432–440

Article  Google Scholar 

Zheng S, Lin R, Chen S et al (2021) Characterization of the benign lesions with increased (68)Ga-FAPI-04 uptake in PET/CT. Ann Nucl Med 35:1312–1320

CAS  Article  Google Scholar 

Tang W, Wang Q, Yang S, Chen Y (2021) Elevated 68Ga-FAPI Activity in the Plasmacytoma of the Ribs. Clin Nucl Med 46:523–524

Article  Google Scholar 

Lin R, Lin Z, Zhang J, Yao S, Miao W (2021) Increased 68Ga-FAPI-04 Uptake in Schmorl Node in a Patient With Gastric Cancer. Clin Nucl Med 46:700–702

Article  Google Scholar 

Pang Y, Zhao L, Chen H (2020) 68Ga-FAPI Outperforms 18F-FDG PET/CT in Identifying Bone Metastasis and Peritoneal Carcinomatosis in a Patient With Metastatic Breast Cancer. Clin Nucl Med 45:913–915

Article  Google Scholar 

Leibel SA, Fuks Z, Zelefsky MJ et al (2002) Intensity-modulated radiotherapy. Cancer J 8:164–176

Article  Google Scholar 

Ishida H, Mohri M, Amats M (2002) Invasion of the skull base by carcinomas: histopathologically evidenced findings with CT and MRI. Eur Arch Otorhinolaryngol 259:535–539

Article  Google Scholar 

Hudgins PA, Baugnon KL (2018) Head and Neck: Skull Base Imaging. Neurosurgery 82:255–267

Article  Google Scholar 

Hamming-Vrieze O, Navran A, Al-Mamgani A, Vogel WV (2018) Biological PET-guided adaptive radiotherapy for dose escalation in head and neck cancer: a systematic review. Q J Nucl Med Mol Imaging 62:349–368

Article  Google Scholar 

Lindner T, Loktev A, Giesel F, Kratochwil C, Altmann A, Haberkorn U (2019) Targeting of activated fibroblasts for imaging and therapy. EJNMMI Radiopharm Chem 4:16

Article  Google Scholar 

Busek P, Mateu R, Zubal M, Kotackova L, Sedo A (2018) Targeting fibroblast activation protein in cancer - Prospects and caveats. Front Biosci (Landmark Ed) 23:1933–1968

CAS  Article  Google Scholar 

Fu K, Pang Y, Zhao L et al (2022) FAP-targeted radionuclide therapy with [177Lu]Lu-FAPI-46 in metastatic nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging 49:1767–1769

CAS  Article  Google Scholar 

Comoretto M, Balestreri L, Borsatti E, Cimitan M, Franchin G, Lise M (2008) Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Radiology 249:203–211

Article  Google Scholar 

Shang Q, Zhao L, PangY YuY, Chen H (2022) 68Ga-FAPI PET/CT Distinguishes the reactive lymph nodes from tumor metastatic lymph nodes in a patient with nasopharyngeal carcinoma. Clin Nucl Med 47:367–368

Article  Google Scholar 

Chen S, Chen Z, Zou G et al (2022) Accurate preoperative staging with [68Ga]Ga-FAPI PET/CT for patients with oral squamous cell carcinoma: a comparison to 2-[18F]FDG PET/CT. Eur Radiol Online. https://doi.org/10.1007/s00330-022-08686-7

Article  Google Scholar